The drug resistance-related protein LRP is the human major vault proteinGeorge L. Scheffer, Rik J. Scheper, Chris J.L.M. Meijer et al.|Nature Medicine|1995Cited by 619
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 BlockadeAleix Prat, Mothaffar F. Rimawi, Tomás Pascual et al.|JNCI Journal of the National Cancer Institute|2019Cited by 168
Trabectedin (T) in relapsed advanced ovarian cancer (ROC): A pooled analysis of three phase II studiesScott McMeekin, C. Sessa, Josep M. del Campo et al.|Journal of Clinical Oncology|2007Cited by 16